Clinical Trials Browser

Lymphoma, Large B-Cell, Diffuse × Lisaftoclax × 1 year × Clear all

NCT07398638 2026-02-10

Lisatoclax Plus R-CHOP or Pola-R-CHP in Untreated DLBCL: A Phase Ib/II Study

Phase 1/2 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse

NCT07159906 2025-09-08

Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1/2 Not yet recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse